Paracetamol and Autism: What the Evidence Really Says – and How Pharmacists Can Reassure Patients

24th September 2025

Recent headlines have reignited questions about whether paracetamol and autism during pregnancy are linked. So, is paracetamol safe in pregnancy? According to the MHRA and NHS, the answer is yes.

For Pharmacists in primary care, these kinds of stories can spark patient anxiety almost overnight. Expectant parents may arrive at consultations worried by what they’ve read online, even when the evidence tells a different story.

At Core Prescribing Solutions, our role is to help healthcare providers cut through noise, lean on trusted guidance, and communicate with patients in ways that reassure and inform. This article explores what the research really shows, why headlines often cause confusion, and how clinical pharmacists and pharmacy technicians can play a vital role in myth-busting.

• Key Takeaways
• MHRA Guidance on Paracetamol in Pregnancy
• What the Evidence Shows
• Why Headlines Cause Confusion
• How Pharmacists Can Reassure Patients
• Core Prescribing Solutions’ Commitment to Primary Care
• Final Thoughts
• FAQs

Key Takeaways

• ✅ Paracetamol remains safe in pregnancy when used as directed.
• ✅ No evidence of a causal link between paracetamol and autism (MHRA, September 2025; supported by large-scale studies).
• ✅ Untreated pain and fever carry risks for mother and baby.
• ✅ Clear, consistent communication is essential to counter headlines.
• ✅ Clinical pharmacists and pharmacy technicians are central to patient reassurance in primary care.

MHRA Guidance on Paracetamol in Pregnancy

On 22 September 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) released a statement confirming there is no evidence that taking paracetamol in pregnancy causes autism in children.

Paracetamol remains the recommended pain relief option during pregnancy when used at the lowest effective dose for the shortest time. The MHRA also reminded patients and pharmacists that untreated pain or fever can itself carry risks – avoiding treatment may be more harmful than appropriate paracetamol use.

Adeem Azhar, CEO at Core Prescribing Solutions, commented:

“Our message is simple and consistent with UK guidance – paracetamol remains the recommended option for pain relief in pregnancy when used appropriately. Headlines come and go, but patients deserve calm, evidence-based advice. That is exactly what our clinical pharmacists deliver every day across Primary Care Networks and GP Practices.”

What the Evidence Shows

The MHRA’s conclusion is supported by:

• Large cohort studies – for example, a 2024 Swedish study of 2.4 million children (PubMed abstract) found no link between paracetamol use in pregnancy and autism diagnoses.
• Systematic reviews – these examine multiple studies, assessing quality and consistency.
• Ongoing safety monitoring – regulators continue to track prescribing and outcomes worldwide.

Some earlier observational studies raised concerns, but these were limited by confounding factors (e.g. whether underlying infection or fever contributed to outcomes). High-quality evidence has not shown a causal link.

The World Health Organisation (WHO) echoed this view in September 2025, stating that “the evidence remains inconsistent” and urging caution against drawing premature conclusions.

Why Headlines Cause Confusion

Despite clear guidance, dramatic headlines often leave patients worried. Social media amplifies partial information, sometimes long before regulators can issue clarifications.

For expectant parents already navigating a vulnerable stage, stories suggesting everyday medicines may harm their baby can fuel unnecessary guilt and anxiety. Pharmacists then face consultations shaped by fear, rather than facts.

This highlights the importance of calm, consistent communication – acknowledging concerns while guiding patients back to trusted evidence.

How Pharmacists Can Reassure Patients

Practical steps for Pharmacists include:

1. Reassure with evidence
   Emphasise that both the MHRA and the NHS confirm paracetamol is safe in pregnancy, with no proven link to autism.
2. Keep language simple
   Use phrases like “The best studies we have show no link” or “The NHS recommends paracetamol as the safest option in pregnancy.”
3. Acknowledge concerns
   Rather than dismissing worry, acknowledge where it comes from:
   “I understand why that headline was worrying – let’s look at what the guidance actually says.”

This approach builds trust and helps prevent patients from avoiding safe, effective treatments.

Core Prescribing Solutions’ Commitment to Primary Care

At Core Prescribing Solutions, we know that reassurance takes time – and time is often in short supply across general practice. That’s where clinical pharmacist services and pharmacy technician support add real value.

They support GP practices and Primary Care Networks by:

• Explaining complex evidence in accessible language.
• Providing accurate reassurance at the point of care.
• Directing patients to trusted resources like NHS and MHRA guidance.
• Ensuring prescribing decisions remain consistent across the network.

By embedding this expertise, practices reduce pressure on GPs while improving patient confidence. To learn more, visit our About Core Prescribing Solutions page.

Final Thoughts

The headlines may grab attention, but the evidence is clear: paracetamol remains the safest pain relief option during pregnancy, with no proven link to autism.

For pharmacists, the challenge is not only knowing the guidance, but also communicating it effectively. With support from Core Prescribing Solutions’ managed workforce models, practices can deliver evidence-based reassurance that protects both patients and outcomes.

FAQs